 Home > Medical News > Medicines Company News > Frontage Pharmaceuticals acquires Ocean Ridge Biosciences to expand genomics services

Frontage Pharmaceuticals acquires Ocean Ridge Biosciences to expand genomics services

 Last Update: 2021-07-08
 Source: Internet
 Author: User

Tags

mixing services

bring ideas life

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 16, Frontage Pharmaceuticals announced the acquisition of Ocean Ridge Biosciences in the United States
.

Ocean Ridge Biosciences is located in Deerfield Beach, Florida, and provides genomics services for customers developing new therapies, including complete service solutions for analyzing RNA expression, DNA polymorphism, methylation, microbial composition, and protein biomarkers in a wide range of samples
.

The company's wet laboratory services can meet ultra-low investment requirements and challenging sample types (such as formalin-fixed paraffin-embedded tissue, skin swabs, and various biological fluids), and are also used in mechanisms such as mechanism of action and lead optimization , Biomarker discovery and development of companion diagnostics and other core application areas

"Ocean Ridge Biosciences has been established for more than 15 years.
It is a next-generation sequencing (NGS) service that uses RNA, mRNA and microRNA arrays as a pioneer in the detection and treatment of disease biomarkers
.

" Executive Vice President, Global Bioanalysis Services, Fangda Pharmaceuticals Dr.

David Willoughby, founder and senior scientist of Ocean Ridge Bioscience, said: “We are very pleased to join the Frontage Pharmaceuticals team to bring a series of unique genomics services developed by Ocean Ridge, which will be provided to customers in the U.
S.
and global industries for a wider range of applications.
Treatment projects.

Ocean Ridge Bioscience will effectively complement Frontage’s current extensive IND and clinical support services, including protein, oligonucleotide, gene and cell therapy R&D services
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.